A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River virus induced arthralgia

Trial Profile

A pilot study to investigate the effects of pentosan polysulfate sodium in Ross River virus induced arthralgia

Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Jul 2017

At a glance

  • Drugs Pentosan polysulfate (Primary)
  • Indications Arthralgia; Ross River virus infections
  • Focus Adverse reactions
  • Acronyms PARA_004
  • Sponsors Paradigm Biopharma
  • Most Recent Events

    • 13 Jul 2017 Planned initiation date changed from 10 Jul 2017 to 20 Jul 2017.
    • 13 Jul 2017 Status changed from not yet recruiting to recruiting.
    • 22 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top